DCM Shriram: The Board approved capital expenditures as per the attachment

What happened

DCM Shriram (DCMSHRIRAM) filed a disclosure with the exchanges on 26 October 2026 at 06:00 PM titled "The Board approved capital expenditures as per the attachment".

Company snapshot

DCM Shriram is a small-cap company in the Diversified sector, with a market value of about ₹15,041 crore.

The stock last traded at ₹964.5, against a 52-week range of ₹886.3–₹1,409 (31.6% below the high).

Before this filing the shares had moved −1.5% over the month and −4.1% over three months. Average daily turnover over the last 20 sessions was about ₹20.37 crore.

Promoters held 66.52% at the end of Q1 FY27. Foreign institutions owned 3.89% and domestic institutions 8.46%.

What history shows

This is not the company's first approval disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.

Market-wide, 1,519 approval filings with an impact score of 50 or more saw an average next-day move of +0.1%, with 47% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

• 26 October 2026: Board meeting — Financial Results/Dividend.

In the news

Recent coverage elsewhere (links open the original publisher):

• DCM Shriram Industries Q1 Results: Net profit falls 85% to ₹1.55 crore — scanx.trade, 19 Oct 2026
• DCM Shriram Fine Chemicals Limited (DSFCL.BO) analyst ratings, estimates and forecasts – Yahoo Finance — Yahoo Finance Singapore, 23 Oct 2026
• Price Band Hitters on October 19, 2026, at 12:00 PM IST: Kross, DCM Shriram Industries, Midwest — HDFC Sky, 19 Oct 2026
• DCM Shriram Limited Annual Report FY 2025-26: Consolidated Net Revenue Rises to Rs. 13,538 Crore, PAT Up 42% — scanx.trade, 25 Oct 2026
• DCM Shriram Share Price Today gains 20% on price action — Univest, 14 Oct 2026

Source

• Exchange filing (PDF)